Sealant

US Capital Global Advises on Multi-Million-Pound Acquisition of Premier Sealant by Red Coast Industries

Retrieved on: 
Tuesday, July 25, 2023

San Francisco, California, USA, July 25, 2023 (GLOBE NEWSWIRE) -- US Capital Global has supported Red Coast Industries Limited, a UK-based industrial investment firm, as debt advisor in its multi-million-pound acquisition of Premier Sealant.

Key Points: 
  • San Francisco, California, USA, July 25, 2023 (GLOBE NEWSWIRE) -- US Capital Global has supported Red Coast Industries Limited, a UK-based industrial investment firm, as debt advisor in its multi-million-pound acquisition of Premier Sealant.
  • All private placements, securities, and other related services are offered by the group’s FINRA-member broker-dealer affiliate, US Capital Global Securities LLC.
  • “We greatly appreciate US Capital Global assisting us as our debt advisor for our recent UK company acquisition,” said  Yossuf and Omar Albanawi, founders and Directors of Red Coast Industries.
  • Red Coast Industries recognized the growth potential in this sector, and we are delighted to have supported them in this successful portfolio acquisition.”

Chase Corporation Announces Fiscal Third Quarter 2023 Results

Retrieved on: 
Thursday, July 6, 2023

Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the third fiscal quarter ended May 31, 2023.

Key Points: 
  • Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the third fiscal quarter ended May 31, 2023.
  • Total Revenue grew 20.3% to $106.6 million, and 27.9% to $303.8 million, in the third quarter and first nine-months of fiscal 2023, respectively
    Gross Margin of 37.7% (40.2% excluding NuCera) in the third quarter of fiscal 2023, compared to 38.6% in the third quarter of fiscal 2022; Gross Margin of 36.5% (39.6% excluding NuCera) in the first nine-months of fiscal 2023, compared to 37.4% in the first-nine months of fiscal 2022
    Net Income was $12.1 million, or $1.27 per diluted share, compared to $15.5 million, or $1.64 per diluted share in the third quarter of fiscal 2022, with the reduction primarily due to additional $3.1 million ($0.24 per diluted share) incremental amortization expense related to the NuCera business
    Free Cash Flow was $21.4 million and $36.1 million in the third quarter and first-nine months of fiscal 2023, respectively, compared to Free Cash Flow of $10.2 million and $17.2 million in the third quarter and first-nine months of fiscal 2022, respectively
    Adjusted EBITDA grew 15.2% to $26.3 million and 28.2% to $73.5 million in the third quarter and first-nine months of fiscal 2023, respectively, compared to Adjusted EBITDA of $22.8 million and $57.3 million in the third quarter and first-nine months of fiscal 2022, respectively
    Adam P. Chase, President and Chief Executive Officer of Chase Corporation, said, “We are pleased by Chase’s continued operational excellence in the fiscal third quarter, including continued progress against our key growth initiatives and inventory reduction efforts.
  • Chase continues to prioritize its proven growth strategy of maintaining financial flexibility, cost management, and minimizing its corporate footprint.
  • Our balance sheet remains healthy with $43 million of cash and a current ratio of 5.2 as of May 31, 2023.

Chase Corporation Announces Fiscal Second Quarter 2023 Results

Retrieved on: 
Thursday, April 6, 2023

Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the second fiscal quarter ended February 28, 2023.

Key Points: 
  • Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the second fiscal quarter ended February 28, 2023.
  • Total Revenue grew 27.5% to $94.3 million, and 32.4% to $197.2 million, in the second quarter and first six-months of fiscal 2023, respectively
    Gross Margin of 36.8% (39.7% excluding our NuCera business) in the second quarter of fiscal 2023, compared to 36.6% in the second quarter of fiscal 2022; Gross Margin of 35.8% (39.2% excluding our NuCera business) in the first six-months of fiscal 2023, compared to 36.8% in the first-six months of fiscal 2022
    Net Income was $8.5 million, or $0.89 per diluted share, compared to $9.1 million, or $0.96 per diluted share in the second quarter of fiscal 2022, – with the reduction primarily due to additional $3.1 million ($0.29 per diluted share) incremental amortization expense related to the NuCera business
    Free Cash Flow was $10.0 million and $14.7 million in the second quarter and first-six months of fiscal 2023, respectively, compared to Free Cash Flow of $1.6 million and $7.0 million in the second quarter and first-six months of fiscal 2022, respectively
    Adjusted EBITDA grew 31.4% to $22.0 million and 36.9% to $47.2 million in the second quarter and first-six months of fiscal 2023, respectively, compared to Adjusted EBITDA of $16.8 million and $34.5 million in the second quarter and first-six months of fiscal 2022, respectively
    Adam P. Chase, President and Chief Executive Officer of Chase Corporation, said, “Despite the historical second quarter unfavorable seasonal impact on revenue compared to our first fiscal quarter, the Company saw increased inorganic growth with our NuCera business and increased revenue from our Industrial Tapes segment’s specialty products and cable materials product lines compared to our prior year second fiscal quarter.”
    Mr. Chase continued, “Consistent with historical patterns, the Company has been impacted by plant shutdowns in Asia due to the Chinese Lunar New Year affecting sales in our Adhesives, Sealants and Additives segment and Industrial Tapes segment’s electronic materials product line compared to our first fiscal quarter which contribute to softening sales in both product line’s Asia-focused markets.
  • Additionally, the Company’s revenue has been impacted by customer de-stocking initiatives affecting all business segments due to improved supply chain conditions.”
    Mr. Chase added, "Our previously announced inventory reduction plan realized results in the second quarter.
  • Our balance sheet remains healthy with $36.4 million of cash and a current ratio of 4.8 as of February 28, 2023.

Chase Corporation Announces Fiscal First Quarter 2023 Results

Retrieved on: 
Thursday, January 5, 2023

Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the first fiscal quarter ended November 30, 2022.

Key Points: 
  • Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the first fiscal quarter ended November 30, 2022.
  • Our revenue growth was also supported by fully realized price increase benefits and rising demand within our Industrial Tapes business.
  • Chase has begun its repayments, allocating $15 million toward our credit revolver balance in the first quarter, and we intend to continue debt payments on a regular basis.
  • In the quarter we also had an income tax rate of 21.8% versus 25.8% in the year ago period.

Global Biosurgery Market Report to 2027 - Insights, Competitive Landscape and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 21, 2022

The "Biosurgery - Global Market Insights, Competitive Landscape and, Market Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Biosurgery - Global Market Insights, Competitive Landscape and, Market Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global biosurgery market can be anticipated to grow at a CAGR of 9.23% during the forecast period of 2022-2027.
  • Key Takeaways from the Biosurgery Market Report Study:
    The effect of the COVID-19 pandemic on this market is significant.
  • To capture and analyze suitable indicators, our experts are closely watching the biosurgery market
    Key companies dominating the global biosurgery market.

Earthfirst® Films Receives Home Compostable Film Certifications from TUV Austria

Retrieved on: 
Friday, November 11, 2022

COLUMBUS, Ohio, Nov. 11, 2022 /PRNewswire/ -- Earthfirst® Films added a line of TUV NF T51-800 certified home compostable films to its existing line of industrial compostable options. PHA in combination with other biopolymers, are engineered for films with at least 85% new carbon content¹. Available in print, sealant and flow wrap films, these new options expand End of Life (EOL) environments as well as provide greater accessibility to a larger consumer base.

Key Points: 
  • Earthfirst Films Expands Film Options With Certified Home Compostable Print, Sealant and Flow Wrap Films
    COLUMBUS, Ohio, Nov. 11, 2022 /PRNewswire/ -- Earthfirst Films added a line of TUV NF T51-800 certified home compostable films to its existing line of industrial compostable options.
  • Inherent in their chemistry, home compostable films are Greenhouse Gas (GHG) favorable to industry fossil-fuel based alternates and naturally lower packaging's carbon footprint.
  • "We are dedicated to bioplastic film innovation and passionate about advancing sustainability for a healthier planet," cited Guenther Winnerl, Earthfirst Films Chief Commercial Officer.
  • Earthfirst Films are DIN CERTCO certified for Industrial Compostability and TUV Austria Certified for Home Compostability.

Earthfirst® Films Receives Home Compostable Film Certifications from TUV Austria

Retrieved on: 
Friday, November 11, 2022

COLUMBUS, Ohio, Nov. 11, 2022 /PRNewswire/ -- Earthfirst® Films added a line of TUV NF T51-800 certified home compostable films to its existing line of industrial compostable options. PHA in combination with other biopolymers, are engineered for films with at least 85% new carbon content¹. Available in print, sealant and flow wrap films, these new options expand End of Life (EOL) environments as well as provide greater accessibility to a larger consumer base.

Key Points: 
  • Earthfirst Films Expands Film Options With Certified Home Compostable Print, Sealant and Flow Wrap Films
    COLUMBUS, Ohio, Nov. 11, 2022 /PRNewswire/ -- Earthfirst Films added a line of TUV NF T51-800 certified home compostable films to its existing line of industrial compostable options.
  • Inherent in their chemistry, home compostable films are Greenhouse Gas (GHG) favorable to industry fossil-fuel based alternates and naturally lower packaging's carbon footprint.
  • "We are dedicated to bioplastic film innovation and passionate about advancing sustainability for a healthier planet," cited Guenther Winnerl, Earthfirst Films Chief Commercial Officer.
  • Earthfirst Films are DIN CERTCO certified for Industrial Compostability and TUV Austria Certified for Home Compostability.

Global Anastomosis Devices Market Report 2022: Increasing Number of Surgical Procedures to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 20, 2022

The "Global Anastomosis Devices Market by Product (Surgical Staplers, Sutures, Sealants & Adhesives), Application (CVDs, GI Surgeries), End-user, and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Anastomosis Devices Market by Product (Surgical Staplers, Sutures, Sealants & Adhesives), Application (CVDs, GI Surgeries), End-user, and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • Growth in this market is mostly driven by the growing incidence of target diseases and the subsequent growth in the number of surgical procedures, the growing demand for minimally invasive surgeries, and technological advancements in anastomosis devices.
  • Surgical Staplers segment accounted for the largest share of the anastomosis devices market, by product
    The anastomosis devices market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives.
  • The global anastomosis devices market is segmented into North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa.

Silicone Adhesives and Sealants Markets: Development of New High Efficient Products will Creates New Growth Opportunities - Global Industry Analysis, Trends, Market Size, and Forecasts to 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 16, 2022

The "Silicone Adhesives and Sealants Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Silicone Adhesives and Sealants Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The report predicts the global silicone adhesives and sealants market to grow with a CAGR of over 5% over the forecast period from 2022-2028.
  • The report on the global silicone adhesives and sealants market provides qualitative and quantitative analysis for the period from 2022 to 2028.
  • The report on silicone adhesives and sealants market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global silicone adhesives and sealants market over the period of 2022 to 2028.

Chase Corporation Announces Closing of Acquisition of NuCera Solutions

Retrieved on: 
Tuesday, September 6, 2022

Chase expects this acquisition to be accretive to earnings within the first year of ownership, with meaningful long-term synergy opportunities.

Key Points: 
  • Chase expects this acquisition to be accretive to earnings within the first year of ownership, with meaningful long-term synergy opportunities.
  • Adam P. Chase, President and Chief Executive Officer of Chase Corporation, commented, We are pleased to have completed this important strategic acquisition.
  • NuCeras culture and technology-driven growth oriented mindset closely align with those of Chase, and we are excited to welcome the NuCera team to Chase Corporation.
  • Steven McKeown, Chief Executive Officer of NuCera, commented, The NuCera team is excited to become an important part of Chase Corporation.